DURHAM, N.C., April 7, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that its Chairman and CEO Chris Stern will present at the Swiss Equity Biotech Conference at the SIX Swiss Exchange Convention Point in Zurich, Switzerland on Tuesday, April 13 at 8 AM (EDT). This conference is presented by Swiss Equity magazine in conjunction with the Swiss Biotech Association and SIX Swiss Exchange. Stern will provide an overview of the company's programs and products. The conference includes presentations by public and privately held companies as well as expert views on current business and science trends. For more information on the conference, visit www.biotechday.ch.
